REFERENCES
- Albert D, Niffenegger A S, Wilson J K. Treatment of metastatic uveal melanoma: Review and recommendations. Surv Ophthalmol 1992; 36: 429–438, [PUBMED], [INFOTRIEVE], [CSA]
- Coupland S, Anastassiou G, Stang A, et al. The prognostic value of cyclin D1, p53, and MDM2 protein expression in uveal melanoma. J Pathol 2000; 191: 120–126, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Seddon J, Albert D M, Lavin P T. A prognostic factor of disease-free interval and survival following enucleation for uveal melnoma. Arch Ophthalmol 1983; 101: 1894–1899, [PUBMED], [INFOTRIEVE], [CSA]
- Channa J, Wilson G D, Cree I A. C-myc, p53 and Bcl-2 expression and clinical outcome in uveal melanoma. Br J Ophthalmol 1999; 83: 110–114, [CSA]
- All-Ericsson C, Girnita L, Seregard S, et al. Insulin-like growth factor-1 receptor in uveal melanoma: A predictor for metastatic disease and a potential therapeutic target. Invest Ophthalmol Vis Sci 2002; 43: 1–8, [PUBMED], [INFOTRIEVE], [CSA]
- Sheidow T, Hooper P L, Crukley C, et al. Expression of vascular endothelial growth factor in uveal melanoma and its correlation with metastasis. Br J Ophthalmol 2000; 84: 750–756, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Smith S, Damato B E, Scholes A GM, et al. Decreased endothelin receptor B expression in large primary uveal melanoms is associated with early clinical metastasis and short survival. Br J Cancer 2002; 87: 1308–1313, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Mooy C, Luyten G P, de Jong P T, et al. Immunohistochemical and prognostic analysis of apoptosis and proliferation in uveal melanoma. Am J Pathol 1995; 147: 1097–1104, [PUBMED], [INFOTRIEVE], [CSA]
- Anastassiou G, Coupland S E, Stang A, et al. Expression of Fas and Fas ligand in uveal melanoma: Biologicial implication and prognostic value. J Pathol 2001; 194: 466–472, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kasof G, Gomes B C. Livin, a novel inhibitor of apoptosis protein family member. J Biol Chem 2001; 276: 3238–3246, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Deveraux Q, Reed J C. IAP family proteins—suppressors of apoptosis. Genes Dev 1999; 13: 239–252, [PUBMED], [INFOTRIEVE], [CSA]
- Adida C, Berrebi D, Peuchmaur M, et al. Anti-apoptosis gene, survivin, and prognosis of neuroblastoma. Lancet 1998; 351: 882–883, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kawasaki H, Altieri D C, Lu C -D, et al. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res. 1998; 58: 5071–5074, [PUBMED], [INFOTRIEVE], [CSA]
- Grossman D, McNiff J M, Li F, et al. Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma. J Invest Dermatol 1999; 113: 1076–1081, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Grossman D, Kim P J, Scheschner J S, et al. Inhibition of melanoma tumor growth in vivo by survivin targeting. Proc Natl Acad Sci USA 2001; 98: 635–640, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Yang D, Welm A, Bishop J M. Cell division and cell survival in the absence of survivin. Proc Natl Acad Sci USA 2004; 19: 15100–15105, [CSA], [CROSSREF]
- Li H, Niederkorn J Y, Neelam S, et al. Resistance and susceptibility of human uveal melanoma cells to TRAIL-induced apoptosis. Arch Ophthalmol 2005; 123: 654–661, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Abu-El-Asrar A, Dralands L, Missotten L, et al. Expression of apoptosis markers in the retinas of human subjects with diabetes. Invest Ophthalmol Vis Sci 2004; 45: 2760–2766, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Adams J, Cory S. The Bcl-2 protein family: Arbiters of cell survival. Science 1998; 281: 1322–1326, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Tang L, Tron V A, Reed J C, et al. Expression of apoptosis regulators in cutaneous malignant melanoma. Clin Cancer Res 1998; 4: 1865–1871, [PUBMED], [INFOTRIEVE], [CSA]
- Schilling H, Sehu K W, Lee W R. A histologic study (including DNMA quantification and Ki-67 labeling index) in uveal melanomas after brachytherapy with ruthenium plaques. Invest Ophthalmol Vis Sci 1997; 38: 2081–2092, [PUBMED], [INFOTRIEVE], [CSA]
- Saornil M, Fisher M R, Campbell R J, et al. Histopathologic study of eyes after iodine 125 episcleral plaque irradiation for uveal melanoma. Arch Ophthalmol 1997; 115: 1395–1400, [PUBMED], [INFOTRIEVE], [CSA]
- Pe'er J, Gnessin H, Shargal Y, et al. PC-10 immunostaining of proliferating cell nuclear antigen in posterior uveal melanoma. Ophthalmology 1994; 101: 56–62, [PUBMED], [INFOTRIEVE], [CSA]
- Pe'er J, Stefani F H, Seregard S, et al. Cell proliferation activity in posterior uveal melanoma after Ru-106 brachytherapy: An EORTC ocular oncology group study. Br J Ophthalmol 2001; 85: 1208–1212, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]